TRIB

Trinity Biotech
TRIB

Overview Fund Trends Analyst Outlook Journalist POV

20 hedge funds and large institutions have $8.92M invested in Trinity Biotech in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 7 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

86% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 7

Holders
20
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$42K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$295K
2
+$42.8K
3
+$14K
4
BlackRock
BlackRock
New York
+$1K

Top Sellers

1
-$1.22M
2
-$735K
3
-$73.8K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$67.7K
5
LPL Financial
LPL Financial
California
-$65.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$2.78M
2
$2.2M
3
$1.84M
4
$931K
5
$502K
6
$295K
7
$120K
8
$60K
9
$57K
10
$37K
11
$33K
12
$30K
13
$14K
14
$13K
15
$1K
16
$1K
17
$1K
18
$1K
19
–
20
–
21
–
22
–
23
–